The 15% Cap That Could Have Broken American Research: Inside the Indirect Cost Rate War

Somewhere in the accounting infrastructure of every major research university is a number that almost nobody outside of grants administration thinks about — until someone tries to change it. That number is the indirect cost rate, also known as the facilities and administrative (F&A) rate, and in 2025 and 2026 it became the most contested figure in American science policy.

The battle over indirect cost rates has played out simultaneously across three branches of government: the executive branch tried to impose a flat 15 percent cap, federal courts struck it down twice, and Congress wrote appropriations language specifically prohibiting it. Yet the Department of Energy went ahead and implemented its own version anyway. The result is a fractured landscape where the rules governing overhead reimbursement now depend on which agency funded your research — a situation without precedent in the modern history of federal R&D.

For any organization that receives federal grants, understanding where this fight stands is no longer optional. It determines how much money actually reaches your institution when you win an award.

What Indirect Costs Actually Pay For

Before the policy debate, the arithmetic. When a university receives a $1 million NIH research grant, the full amount does not go to the laboratory. A portion covers direct costs — researcher salaries, equipment, reagents, travel. The remainder covers indirect costs: the lights in the building where the lab operates, the HVAC system that keeps the clean room at spec, the grants administration office that manages compliance reporting, the library subscriptions that provide access to published research, the environmental health and safety team that inspects the lab.

These costs are real. They represent the institutional infrastructure that makes federally funded research possible. Without them, there is no research university — just a collection of principal investigators with no facilities, no support staff, and no compliance apparatus.

The mechanism for determining how much overhead the federal government reimburses is the negotiated indirect cost rate agreement (NICRA). Each institution negotiates its rate with a cognizant federal agency — usually the Department of Health and Human Services for universities — based on audited cost data. The resulting rate reflects that specific institution's actual overhead costs.

Rates vary enormously. A major research university with extensive facilities, medical centers, and compliance infrastructure might negotiate a rate of 55 to 68 percent. A smaller institution with lower overhead might land at 30 to 45 percent. A nonprofit without a negotiated rate can use the de minimis rate of 10 percent.

In FY2023, NIH alone reimbursed approximately $12.6 billion in indirect costs across all grantees. That figure represents roughly 27 percent of NIH's total extramural budget — money that keeps research infrastructure operational at hundreds of institutions nationwide.

The 15% Cap: What the Administration Tried to Do

In February 2025, NIH published supplemental guidance (NOT-OD-25-068) that would have replaced every institution's individually negotiated rate with a flat 15 percent indirect cost rate for NIH grants. The stated rationale was efficiency: more money flowing directly to research, less consumed by overhead.

The math was stark. A university with a negotiated rate of 55 percent receiving a $2 million NIH grant would typically receive approximately $1.29 million in direct costs and $710,000 in indirect cost reimbursement. Under the 15 percent cap, the indirect reimbursement would drop to approximately $261,000 — a loss of $449,000 per award. Across a portfolio of dozens or hundreds of NIH grants, the institutional losses would run into tens or hundreds of millions of dollars annually.

A New York Times analysis found that some top research universities stood to lose over $100 million per year. Johns Hopkins, the largest recipient of NIH funding, estimated the cap would cost the institution $375 million annually. The Association of American Universities calculated the aggregate impact at $7.9 billion per year across the research university sector.

The policy did not just threaten budgets. It threatened the financial model that sustains American research universities. Indirect cost reimbursements subsidize the facilities, staff, and compliance systems that make federal research possible. Cutting them by 60 to 75 percent without a corresponding reduction in compliance requirements would force institutions to either subsidize federal research from other revenue sources or stop accepting federal grants altogether.

The Courts Intervene — Twice

The legal challenge came fast. A coalition of universities and research institutions filed suit in the U.S. District Court for the District of Massachusetts, arguing that the 15 percent cap violated both a federal appropriations rider prohibiting the replacement of negotiated rates with a uniform rate and NIH's own regulations governing the negotiation process.

On April 4, 2025, the district court permanently enjoined the Department of Health and Human Services from implementing the policy. The court found that the guidance effectively replaced the negotiated rate system Congress had mandated and funded, constituting an unauthorized policy change that bypassed the notice-and-comment rulemaking process required by the Administrative Procedure Act.

HHS appealed to the First Circuit Court of Appeals. On January 6, 2026, the First Circuit affirmed the district court's ruling, upholding the permanent injunction and vacating the guidance entirely. The appellate panel cited two independent legal bases: the appropriations rider and NIH's own regulatory framework, both of which require individually negotiated rates rather than uniform caps.

The court noted, carefully, that "other mechanisms are available to the NIH to lawfully change indirect cost rates" — leaving the door open for a properly noticed rulemaking process but closing it firmly against administrative guidance that tries to circumvent negotiation.

Congress Reinforces the Firewall

The courts blocked the NIH cap, but Congress went further. The FY2026 appropriations package, signed into law in late January, includes explicit statutory language extending the appropriations rider that prohibits federal agencies from replacing negotiated indirect cost rates with a uniform rate. The rider applies across HHS — not just NIH — and has been interpreted by appropriations committee staff as covering the broader federal research enterprise.

The House report language accompanying the spending bills goes further still, acknowledging the work of the Joint Associations Group on Indirect Costs in developing the Financial Accountability in Research (FAIR) model and directing agencies to work with the research community on overhead reform rather than imposing caps unilaterally.

For the moment, the combination of court injunctions and congressional riders creates a strong legal and legislative barrier against flat-rate indirect cost caps at NIH and across HHS. The appropriations language must be renewed annually, but removing it would require affirmative congressional action — a much higher bar than letting it lapse.

The DOE Exception: One Agency Went Its Own Way

While courts and Congress blocked the NIH cap, the Department of Energy quietly implemented its own version. On April 11, 2025, DOE announced updated policies establishing a standardized 15 percent indirect cost rate for all new grant awards to institutions of higher education.

DOE's legal position is different from NIH's. The appropriations rider that blocks uniform rates at HHS does not explicitly cover DOE. The department argues that its action falls within existing regulatory authority and does not require the same negotiation framework that governs NIH rates.

For universities with significant DOE-funded research portfolios — particularly in high-energy physics, nuclear science, materials research, and climate science — the impact is immediate and severe. An institution with a negotiated rate of 52 percent accepting a new DOE grant now receives indirect cost reimbursement at 15 percent. The 37-percentage-point gap comes directly out of institutional resources.

The DOE policy has not faced a court challenge of the same magnitude as the NIH cap, in part because the legal basis is different and in part because the affected research community is smaller. But the precedent is troubling: if one agency can unilaterally impose a 15 percent rate, others may follow. The Department of Defense, the National Science Foundation, and NASA each have their own indirect cost frameworks, and each faces pressure from the same executive order that motivated the NIH and DOE actions.

Executive Order 14332: The Preference That Changed the Game

Even where the 15 percent cap has been blocked, Executive Order 14332 — signed August 7, 2025 — introduced a softer but potentially more durable mechanism: a directive that "all else being equal, preference for discretionary awards should be given to institutions with lower indirect cost rates."

This preference does not cap rates. It does not replace negotiated agreements. But it creates a new competitive dimension in grant review processes. Two otherwise equal proposals from two institutions — one with a 55 percent F&A rate and one with a 35 percent rate — should now be evaluated with the lower-rate institution receiving preference.

The practical impact is still emerging. Agency program officers are interpreting the preference differently across divisions and directorates. Some treat it as a tiebreaker in competitive reviews. Others have incorporated indirect cost rates into scoring rubrics. At minimum, it introduces a factor that was never part of the peer review process before: the cost of doing business at the applicant's institution, a variable the applicant cannot control.

For smaller institutions — community colleges, primarily undergraduate universities, and nonprofits with lower overhead — the preference could represent a meaningful competitive advantage. For major research universities with negotiated rates above 50 percent, it adds a structural headwind that compounds with every competition.

What This Means for Grant Seekers in 2026

The indirect cost landscape is now split across agencies, legal jurisdictions, and policy frameworks in ways that require institution-level strategy.

Know your rate and how it compares. If you are at an institution with a negotiated rate above 50 percent, understand that your proposals now carry a higher cost profile than competitors at lower-rate institutions. This does not make you ineligible — negotiated rates remain the standard at NIH, NSF, and most agencies — but the EO 14332 preference means reviewers may be considering this factor for the first time.

Watch DOE carefully. If your research portfolio includes DOE grants, model the financial impact of the 15 percent cap on new awards. Existing awards under previously negotiated rates are grandfathered, but every new DOE grant will use the 15 percent rate until the policy is reversed or challenged.

Consider the de minimis alternative. For smaller nonprofits and organizations without a NICRA, the 10 percent de minimis rate is now strategically interesting. It is lower than any negotiated rate and positions your proposals favorably under the EO 14332 preference framework. The tradeoff is that it may not cover your actual overhead costs, requiring cross-subsidization from other revenue.

Advocate through your institution. The FAIR model, supported by the Joint Associations Group, proposes reforms to indirect cost accounting that would increase transparency without imposing uniform caps. If your institution is not engaging with this process, it should be. The next round of appropriations riders will be negotiated later this year, and the strength of the research community's unified position determines whether the firewall holds.

Track the legal landscape. The First Circuit ruling applies nationally through injunction but could be challenged in other circuits. A Supreme Court case on indirect cost authority is not out of the question if the executive branch decides to pursue formal rulemaking. The legal ground is more stable than it was a year ago, but it is not settled.

The battle over indirect cost rates is, at its core, a battle over who pays for the infrastructure that makes American research possible. The answer to that question will shape every federal grant competition for the rest of the decade.

For institutions navigating this shifting landscape and looking for funding opportunities that match their cost structures, Granted tracks programs across 144 federal, state, and foundation sources — helping you find the right fit in a funding environment that just got more complicated.